Neurocrine Biosciences shares owned by UBS Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51M | 365k | 140.38 |
| 2025-06-30 | $77M | 615k | 125.69 |
| 2025-03-31 | $87M | 786k | 110.60 |
| 2024-12-31 | $57M | 419k | 136.50 |
| 2024-09-30 | $41M | 360k | 115.22 |
| 2024-06-30 | $44M | 317k | 137.67 |
| 2024-03-31 | $33M | 236k | 137.92 |
| 2023-12-31 | $19M | 144k | 131.75 |
| 2023-09-30 | $15M | 134k | 112.50 |
| 2023-06-30 | $12M | 123k | 94.30 |
| 2023-03-31 | $13M | 125k | 101.22 |
| 2022-12-31 | $26M | 217k | 119.44 |
| 2022-09-30 | $16M | 152k | 106.05 |
| 2022-06-30 | $15M | 156k | 97.57 |
| 2022-03-31 | $28M | 297k | 94.02 |
| 2021-12-31 | $27M | 313k | 85.31 |
| 2021-09-30 | $17M | 176k | 96.07 |
| 2021-06-30 | $14M | 141k | 97.44 |
| 2021-03-31 | $8.9M | 92k | 97.25 |
| 2020-12-31 | $1.5M | 16k | 98.04 |
| 2020-09-30 | $1.6M | 16k | 96.16 |
| 2020-06-30 | $7.2M | 59k | 122.05 |
| 2020-03-31 | $7.8M | 90k | 86.55 |
| 2019-12-31 | $8.1M | 75k | 107.45 |
| 2019-09-30 | $9.4M | 105k | 90.11 |
| 2019-06-30 | $5.0M | 59k | 84.40 |
| 2019-03-31 | $6.3M | 72k | 88.13 |
| 2018-12-31 | $11M | 148k | 71.40 |
| 2018-09-30 | $5.2M | 42k | 122.94 |
| 2018-06-30 | $1.1M | 11k | 98.21 |
| 2018-03-31 | $5.1M | 61k | 82.91 |
| 2017-12-31 | $1.8M | 24k | 77.52 |
| 2017-09-30 | $1.4M | 24k | 61.31 |
| 2017-06-30 | $1.6M | 35k | 45.99 |
| 2017-03-31 | $1.9M | 45k | 43.29 |
| 2016-12-31 | $1.7M | 45k | 38.70 |
| 2016-09-30 | $3.4M | 66k | 50.64 |
| 2016-06-30 | $6.6M | 146k | 45.62 |
| 2016-03-31 | $1.4M | 35k | 39.38 |
| 2015-12-31 | $3.1M | 55k | 56.57 |
| 2015-09-30 | $645k | 16k | 39.81 |
| 2015-03-31 | $3.8M | 94k | 40.00 |